National Research Co. (NASDAQ:NRC) major shareholder Amandla Mk Trust sold 12,198 shares of the stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $64.68, for a total transaction of $788,966.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
Amandla Mk Trust also recently made the following trade(s):
- On Thursday, August 15th, Amandla Mk Trust sold 19,000 shares of National Research stock. The shares were sold at an average price of $64.72, for a total transaction of $1,229,680.00.
Shares of NRC stock traded down $0.52 during trading hours on Monday, hitting $64.37. The company’s stock had a trading volume of 41,689 shares, compared to its average volume of 34,360. The business has a fifty day moving average of $34.00 and a 200-day moving average of $30.88. The stock has a market cap of $1.59 billion, a price-to-earnings ratio of 61.89 and a beta of 0.80. National Research Co. has a twelve month low of $35.58 and a twelve month high of $68.86. The company has a current ratio of 0.62, a quick ratio of 0.58 and a debt-to-equity ratio of 1.24.
About National Research
National Research Corporation (NRC) is a provider of analytics and insights that facilitate revenue growth, patient, employee and customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. The Company’s portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.
Featured Story: What is the definition of market timing?
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.